Analysis Of Income And Expense [Abstract]

Alligator Bioscience - Filing #679585

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Analysis of income and expense [abstract]
Material income and expense [abstract]
Finance income (cost)	—	—	397,000 SEK	—	—	614,000 SEK	—	—
Miscellaneous other operating expense	—	—	2 227 SEK	—	—	1 597 SEK	—	—
Revenue and other operating income	—	—	61 902 SEK	—	—	37 135 SEK	—	—
Expenses by nature [abstract]
Classes of employee benefits expense [abstract]
Employee benefits expense	—	—	79 377 SEK	—	—	68 836 SEK	—	—
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense	—	—	10 489 SEK	—	—	11 767 SEK	—	—
Other expenses, by nature	—	—	218 792 SEK	—	—	147 725 SEK	—	—
Expenses, by nature	—	—	310 884 SEK	—	—	229 925 SEK	—	—
Disclosure of attribution of expenses by nature to their function [text block]	—	—	—	—	—	—	—	—
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	- SEK	- SEK	248 586 SEK	248 586 SEK	- SEK	193 403 SEK	193 403 SEK	- SEK